Rhinostop - instructions for use, dose, side effects, contraindications

Xylometazoline belongs to the group of local vasoconstrictors (decongestants) with alpha-adrenomimetic activity, causes narrowing of the blood vessels of the nasal mucosa, thus eliminating the edema and hyperemia of the nasal mucosa, restoring the nasal passages, facilitating nasal breathing.

The effect of the drug comes in a few minutes after its application and lasts up to 10 hours.

Pharmacokinetics:

With topical application, the drug is practically not absorbed, therefore its concentration in the blood plasma is very low (it is not determined by modern analytical methods).

Indications:

Applied in acute respiratory diseases with the phenomena of rhinitis (rhinitis), acute allergic rhinitis, sinusitis, with average otitis (as part of a combination therapy to reduce edema of the nasopharyngeal mucosa), to facilitate the conduct of a rhinoscopy.

Contraindications:

Hypersensitivity to xylometazoline, arterial hypertension, tachycardia, severe atherosclerosis, glaucoma, atrophic rhinitis, hyperthyroidism, surgical interventions on the meninges (in the anamnesis), pregnancy, lactation period, children's age (up to 2 years for 0.05% solution, up to 6 years for 0.1% solution).
Do not use with monoamine oxidase inhibitors and tricyclic antidepressants.

Carefully:

Carefully - with diabetes, ischemic heart disease (angina), prostatic hyperplasia.

Pregnancy and lactation:contraindicated

Dosing and Administration:

Adults and children over 6 years of age, 1-2 drops of 0.1% xylometazoline solution are injected into each nasal passage 2-3 times a day.

Children from 2 to 6 years are used 0.05% solution for 1-2 drops in each nasal passage 1-2 times a day.

Do not apply the drug without interruption for more than 3-5 days.

Side effects:

With frequent and / or prolonged use - irritation and / or dryness of the mucous membrane of the nasopharynx, burning, tingling, sneezing, hypersecretion; rarely - swelling of the nasal mucosa, vomiting, headache, palpitation, increased blood pressure, tachycardia, arrhythmia, insomnia, visual impairment, depression (with prolonged use of high doses).

Overdose:

Symptoms: increased side effects. Treatment: symptomatic under the supervision of a physician.

Interaction:

It is possible to enhance the systemic effect while using inhibitors of 1 | LAO and tricyclic antidepressants.

Special instructions:

Do not use for a long time, for example, with chronic rhinitis.

Effect on the ability to drive transp. cf. and fur:When the dosing regimen is observed xylometazoline does not affect the concentration of attention. In dosages exceeding the recommended dosage, the drug may affect the ability to drive a vehicle or equipment. Do not exceed the recommended dose and increase the duration of treatment.

Form release / dosage:

Nasal drops 0.05 % and 0.1%.

Packaging:10 ml or 20 ml in glass bottles, ukuporennye stoppers rubber with a rolling off caps aluminum. For 10 ml or 15 ml in a bottle-dropper polymer with the control of the first dissection. 1 bottle of glass complete with a lid-dropper polyethylene or 1 bottle-dropper polymer together with instructions for use in a pack of cardboard.

Storage conditions:

In the dark place at a temperature of 0 ° C.up to + 25 ° С.

Keep out of the reach of children.

Shelf life:

3 years. Do not use the drug after the expiration date.

Terms of leave from pharmacies:Without recipe

Registration number:P N002182 / 01

Date of registration:16.01.2009

The owner of the registration certificate:PHARMSTANDART-FORESTRY, OJSC PHARMSTANDART-FORESTRY, OJSC Russia

Manufacturer: & nbsp

LEKKO, ZAO Russia

Information update date: & nbsp23.04.2014

Illustrated instructions

Instructions

Rhinostop (Rinostop)